S2-6. Biomarkers For Immuno-Checkpoint Inhibitors von Fred R.Hirsch

Volltext

S14-1 PD-L1 IHC AS A PREDICTIVE ASSAY FOR CHECKPOINT INHIBITORS : FACTS AND PITFALLS von Fred R.Hirsch

Volltext

Consensus Report of a Joint NCI Thoracic Malignancies Steering Committee: FDA Workshop on Strategies for Integrating Biomarkers into Clinical Development of New Therapies for Lung... von Malik, Shakun M., Pazdur, Richard, Abrams, Jeffrey S., Socinski, Mark A., Sause, William T., Harpole, David H., Welch, John J., Korn, Edward L., Ullmann, Claudio Dansky, Hirsch, Fred R.

Volltext

Educational Session 1-1 Targeted Molecules for Lung Cancer Diagnosis and Therapy von Fred R.Hirsch

Volltext

S10-5 SQUIRE : Gemcitabine-cisplatin(GC) + necitumumab vs. GC alone in first-line squamous non-small cell lung cancer von Nick Thatcher, Fred R.Hirsch, Aleksandra Szczesna, Tudor-Eliade Ciuleanu, Wojciech Szafranski, Mircea Dediu, Rodryg Ramlau, Rinat Galiulin, Beatrix Balint, Gyorgy Losonczy, Andrzej Kazarnowicz, Keunchil Park, Christian Schumann, Martin Reck, Luis Paz-Ares, Henrik Depenbrock, Shivani Nanda, Anamarija Kruljac-Letunic, Mark A.Socinski

Volltext